New research suggests that patients who come off new weight-loss injections like Wegovy and Mounjaro may regain shed pounds at a significantly accelerated pace than those who stop traditional lifestyle programs.
Findings released in a major health publication shows that while overweight people can lose about a fifth of their body weight while on the medication, the mass is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"People using such medications should be aware of the potential of quick weight regain when the medication concludes," cautioned researcher Dr. Susan Jebb.
This pace of recovery means a return to pre-treatment weight in about one and a half years.
Weighing Therapies
The analysis, which looked at 37 of trials involving thousands of participants, contrasted the effects of the injectable medications with other pills.
The team emphasize that people who shed pounds through diet and exercise usually see a slower creep back—perhaps 100 grams monthly—post-intervention.
Explaining the Rapid Rebound
Experts believe the way of the jabs explains the accelerated rebound.
These medications mimic a natural hormone called GLP-1, which moderates hunger.
"Sustained high doses of the hormone concentrations several times higher than normal could lead to the body to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this medication means appetite is unsuppressed, making binge eating far more likely."
A Chronic Condition?
Health authorities suggest the jabs for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.
Many experts say that, considering the likelihood of relapse, the therapy should be considered ongoing.
This opinion is echoed by pharmaceutical companies, who say that the findings "highlight the persistent nature of excess weight," similar to managing diseases like diabetes.
Patient Experiences
Individuals who have discontinued the medication describe a sudden return of appetite.
"It felt as if something activating and you become ravenous," said one woman.
The struggle is exacerbated if patients have not adopted permanent lifestyle or habit changes during treatment.
Widespread Adoption
Recent estimates indicate that millions of people in the UK have used these injections in the past year, with demand remaining high.
- Adoption is higher among women compared to men.
- The middle-aged age group shows the greatest level of interest.
- A large proportion access the medications through private healthcare rather than public health services.
Finally, clinicians emphasize that while these medications are powerful tools for weight loss, they are not a standalone cure and lasting health benefits likely depends on combined behavioural support.